Doctors recommend menopause medicine as pharmacies face shortages

The FDA acknowledges ongoing shortages of estrogen patches used for menopause treatment, caused by increased demand following the removal of a black box warning and manufacturing limitations. While the agency is working with six manufacturers to boost supply, women continue to struggle with access, and some are turning to alternative therapies. Experts emphasize the importance of continued treatment and suggest trying different formulations or sources while the supply issues persist.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل